SPDR S&P Pharmaceuticals ETF - 5 year dividend growth rate
Dividend history for stock XPH (SPDR S&P Pharmaceuticals ETF) including dividend growth rate predictions based on history.
Year | Dividend | Estimated Yield on Cost |
---|---|---|
2034 | 2.980USD * | 7.39% |
2033 | 2.549USD * | 6.32% |
2032 | 2.180USD * | 5.40% |
2031 | 1.864USD * | 4.62% |
2030 | 1.594USD * | 3.95% |
2029 | 1.363USD * | 3.38% |
2028 | 1.166USD * | 2.89% |
2027 | 0.997USD * | 2.47% |
2026 | 0.853USD * | 2.11% |
2025 | 0.729USD * | 1.81% |
2024 | 0.624USD * | 1.55% |
2023 | 0.533USD | |
2022 | 0.672USD | |
2021 | 0.439USD | |
2020 | 0.245USD | |
2019 | 0.291USD | |
2018 | 0.239USD | |
2017 | 0.292USD | |
2016 | 0.246USD | |
2015 | 3.662USD | |
2014 | 2.998USD | |
2013 | 0.905USD | |
2012 | 0.533USD | |
2011 | 0.294USD | |
2010 | 0.259USD | |
2009 | 0.188USD | |
2008 | 0.235USD | |
2007 | 0.186USD | |
2006 | 0.131USD |
* These yearly dividends are calculated as current last years dividends times conservative dividend growth rate. Conservative dividend growth rate is calculated from DGR5 value and uses this function (in XPH case 16.93% was used as conservative DGR).
XPH
Price: $40.33
Dividend Yield: 0.01%
Forward Dividend Yield: 1.72%
Payout Ratio: 24.91%
Dividend Per Share: 0.69 USD
Earnings Per Share: 2.78 USD
P/E Ratio: 15.30
Exchange: PCX
Volume: 26100
Market Capitalization: 228.9 million
Average Dividend Frequency: 4
Years Paying Dividends: 19
DGR3: 30.00%
DGR5: 24.13%
DGR10: 30.00%